联想集团Q1再创史上最佳业绩，AI服务器业务迎来爆发期
Ranking
No observed public metrics; popularity remains neutral/archived.
Merged summary
TL;DR — 联想集团实现创纪录的 fiscal Q1 业绩，营收同比增长43%，调整后净利润增长176%。AI基础设施、推理需求及超大规模客户支出成为主要增长动力。
- 季度营收达1834亿元人民币，调整后净利润超过73亿元人民币。
- 基础设施方案业务集团营收创纪录地达到579亿元，运营利润率为9.1%。
- AI相关营收同比增长60%至634亿元，约占总营收35%；AI服务营收增长141%。
- 联想重点布局混合式AI基础设施、推理与Token生成效率，同时推进AI PC和企业智能体。
注： DrugAI来源描述的是Aureka Biotechnologies融资及AI药物研发，与联想Q1业绩并非同一项工作，故未合并。
Sources (2)
联想集团Q1再创史上最佳业绩，AI服务器业务迎来爆发期
TL;DR - Lenovo reported record fiscal Q1 revenue and adjusted profit, driven partly by surging AI infrastructure demand. Its infrastructure unit nearly doubled revenue as inference workloads and hyperscaler spending accelerated.
- Quarterly revenue rose 43% year over year to RMB 183.4 billion; adjusted net profit increased 176% to over RMB 7.3 billion.
- Infrastructure Solutions Group revenue reached a record RMB 57.9 billion, with a 9.1% operating margin.
- AI-related revenue grew 60% to RMB 63.4 billion, about 35% of total revenue; AI services revenue rose 141%.
- Lenovo is emphasizing hybrid AI infrastructure, inference and token-generation efficiency, alongside AI PCs and enterprise agents.
寻明生科获1亿美元融资，加码基座模型开拓AI药物发现新边界
TL;DR - Aureka Biotechnologies raised $100 million in Series B funding to scale its biological foundation models and closed-loop AI drug-discovery infrastructure. The investment supports its shift from improving individual discovery tasks toward modeling and designing complex biological systems.
- Funding will expand AuraIDE’s training for de novo molecular design, structure modeling, functional prediction, and multi-objective optimization.
- Its Lab-in-the-Loop system feeds high-throughput experiments and single-cell functional screens back into model training and reinforcement learning.
- AI agents coordinate target analysis, molecule generation, computational evaluation, experiment design, and results analysis.
- Aureka reports strategic pharmaceutical partnerships and multimillion-dollar commercial revenue, while pursuing a longer-term biological world model.